Healthcare AI: What’s in your chatbot?
By OWEN TRIPP So much of the early energy around generative AI in healthcare has…
Healthcare AI: What’s in your chatbot?
By OWEN TRIPP So much of the early energy around generative AI in healthcare has been geared toward speed and efficiency: freeing doctors from admin tasks, automating patient intake, streamlining paperwork-heavy pain points. This is all necessary and helpful, but much of it boils down to established players optimizing the existing system to suit their…
A deeper dive into drug revenue and cost
Many people don’t understand why pharmaceuticals cost so much money. Don’t pharmaceutical companies make a lot of money? The answer is ‘yes’, but only if the drugs are successful. A paper by Wouters et al. (2024) found that: Based on data for 361 of 558 new therapeutic agents approved over the study period (median follow-up…
Dominique Wells, Conduit Health Partners
Dominique Wells is COO of Conduit Health Partners which is a spin off from the (now) Bon Secours Mercy Health system. Their role is to provide back up for nursing staff for health systems in very specific areas, notably patient transfer operations, nurse triage and patient communications. Dominque and her team showed me a brief…
ACA Marketplace Insurers Proposing 15% Median Premium Increase in 2026
Most ACA Marketplace insurers are requesting premium increases between 10% and 20% for 2026, according to a new analysis. More than a quarter (27%) are requesting increases of 20% or more. The post ACA Marketplace Insurers Proposing 15% Median Premium Increase in 2026 appeared first on MedCity News.
Victoria DeFrancesco Soto Joins KFF Board of Trustees
San Francisco – KFF announced today that Dr. Victoria DeFrancesco Soto has joined KFF’s Board of Trustees. DeFrancesco Soto is the Dean of the Clinton School of Public Service at the University of Arkansas and previously served as Assistant Dean at the LBJ School of Public Affairs at the University of Texas at Austin. She…More
Roche Reports Mixed Data for Drug Trying to Jump on the Biologic Bandwagon in COPD
Roche’s astegolimab met the main goal of one pivotal COPD study but failed another, mirroring the mixed results recently posted by a Regeneron Pharmaceuticals COPD drug candidate that goes after the same target. Biologics are a new treatment option for COPD following approvals of antibodies from Sanofi and GSK. The post Roche Reports Mixed Data…
New Policy Bars Many Lawfully Present and Undocumented Immigrants from a Broad Range of Federal Health and Social Supports
This policy watch discusses a recent policy change by the Department of Health and Human Services that bars several groups of immigrants from accessing an updated list of “federal public benefits”.
The Best Physical Therapy Ice Packs on Amazon: 2025 Buyer’s Guide
[Sponsored] Physical therapy is already a good step toward pain management and relief. Combine it with cold therapy by using ice packs for better results. The post The Best Physical Therapy Ice Packs on Amazon: 2025 Buyer’s Guide appeared first on MedCity News.
Why Leadership Is the Missing Link in Patient Safety Reform
Patient safety has lost its place on the priority list. Without strong, sustained attention from those at the top, safety efforts rarely take root. The post Why Leadership Is the Missing Link in Patient Safety Reform appeared first on MedCity News.
Navigating the Path to Success in Medical Devices: Strategy, Reimbursement, and Competition
The keys are establishing a culture that applauds ideas and learns from “failures” rather than seeking to place blame, recognizing that the best ideas can come from any source, and benefiting from cross-functional discussion and challenge. The post Navigating the Path to Success in Medical Devices: Strategy, Reimbursement, and Competition appeared first on MedCity News.
